Selective Use of Episiotomy: the Impact on Perineal Trauma.
NCT ID: NCT03559816
Last Updated: 2022-05-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
10000 participants
OBSERVATIONAL
2021-02-01
2022-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We designed a prospective observational study with the introduction of a new classification of perineal trauma recorded with the usual data retrieved in delivery ward register. The aim is to definitively investigate if selective use of episiotomy reduce the overall perineal trauma.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Study Comparing Two Classification Systems for Second-degree Vaginal Tears During Spontaneous Childbirth to Assess Their Ability to Predict Postpartum Complications.
NCT07124676
Mediolateral Episiotomy and Obstetric Anal Sphincter Injuries in Instrumental Delivery
NCT04446780
Comparison of Never Performing Episiotomy to Performing it in a Selective Manor
NCT02178111
Early Resuturing Versus Expectant Management Following Perineal Wound Dehiscence Among Women Who Had a Vaginal Delivery
NCT03806348
Continuous Versus Discontinuous Suture in the Perineals Lesions
NCT03825211
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Selective use of Episiotomy
Vaginal delivery assisted with selective use of episiotomy and prospective classification of perineal laceration with a sub-classification of second-degree tears. Data of subclassifications are registered with data usually recorded in delivery ward register.
Classification of perineal tears based on new classification
Classifications according to the American College of Obstetricians and Gynaecologists (ACOG) and the Royal College of Obstetricians and Gynaecologists (RCOG) and sub classification of second-degree lacerations based on the assumption that episiotomy involves the same anatomic structures of a second-degree laceration (perineal muscle, mucosa and skin), and divides them in two sub-groups, named A (if spontaneous vaginal tear is smaller than episiotomy) and B (if spontaneous vaginal tear is bigger than episiotomy).
Selective use of Episiotomy
Standardized selective use of Episiotomy as recommended by guidelines.
Not selective use of Episiotomy
Vaginal delivery assisted without a selective use of episiotomy. Data retrospectively retrieved by delivery ward register that were usually recorded.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Classification of perineal tears based on new classification
Classifications according to the American College of Obstetricians and Gynaecologists (ACOG) and the Royal College of Obstetricians and Gynaecologists (RCOG) and sub classification of second-degree lacerations based on the assumption that episiotomy involves the same anatomic structures of a second-degree laceration (perineal muscle, mucosa and skin), and divides them in two sub-groups, named A (if spontaneous vaginal tear is smaller than episiotomy) and B (if spontaneous vaginal tear is bigger than episiotomy).
Selective use of Episiotomy
Standardized selective use of Episiotomy as recommended by guidelines.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universita di Verona
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Simone Garzon
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Simone Garzon, M.D.
Role: PRINCIPAL_INVESTIGATOR
Univerisity of Verona
Massimo Franchi, M.D.
Role: PRINCIPAL_INVESTIGATOR
Univerisity of Verona
Francesca Parissone, M.D.
Role: PRINCIPAL_INVESTIGATOR
Univerisity of Verona
Cecilia Lazzari, M.D.
Role: PRINCIPAL_INVESTIGATOR
Univerisity of Verona
Antonio Simone Laganà, M.D.
Role: PRINCIPAL_INVESTIGATOR
Università degli Studi dell'Insubria
Giovanni Zanconato, M.D.
Role: PRINCIPAL_INVESTIGATOR
Universita di Verona
Ricciarda Raffaelli, M.D.
Role: PRINCIPAL_INVESTIGATOR
Universita di Verona
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AOUI Verona - University of Verona - Department of Obstetrics and Gynecology
Verona, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SEPT-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.